Literature DB >> 23024028

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.

Dinesh Khanna1, John D Fitzgerald, Puja P Khanna, Sangmee Bae, Manjit K Singh, Tuhina Neogi, Michael H Pillinger, Joan Merill, Susan Lee, Shraddha Prakash, Marian Kaldas, Maneesh Gogia, Fernando Perez-Ruiz, Will Taylor, Frédéric Lioté, Hyon Choi, Jasvinder A Singh, Nicola Dalbeth, Sanford Kaplan, Vandana Niyyar, Danielle Jones, Steven A Yarows, Blake Roessler, Gail Kerr, Charles King, Gerald Levy, Daniel E Furst, N Lawrence Edwards, Brian Mandell, H Ralph Schumacher, Mark Robbins, Neil Wenger, Robert Terkeltaub.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23024028      PMCID： PMC3683400          DOI： 10.1002/acr.21772

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN： 2151-464X            Impact factor:   4.794


× No keyword cloud information.
  63 in total

1.  Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment.

Authors:  Lisa K Stamp; John L O'Donnell; Mei Zhang; Jill James; Christopher Frampton; Murray L Barclay; Peter T Chapman
Journal:  Arthritis Rheum       Date:  2011-02

Review 2.  American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.

Authors:  Jennifer M Grossman; Rebecca Gordon; Veena K Ranganath; Chad Deal; Liron Caplan; Weiling Chen; Jeffrey R Curtis; Daniel E Furst; Maureen McMahon; Nivedita M Patkar; Elizabeth Volkmann; Kenneth G Saag
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-07-26       Impact factor: 4.794

3.  Risk factors associated with renal lithiasis during uricosuric treatment of hyperuricemia in patients with gout.

Authors:  Fernando Perez-Ruiz; Samuel Hernandez-Baldizon; Ana M Herrero-Beites; Miguel A Gonzalez-Gay
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-09       Impact factor: 4.794

Review 4.  Risk factors for gout and prevention: a systematic review of the literature.

Authors:  Jasvinder A Singh; Supriya G Reddy; Joseph Kundukulam
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

Review 5.  Chronic gout: epidemiology, disease progression, treatment and disease burden.

Authors:  Richard A Brook; Anna Forsythe; James E Smeeding; N Lawrence Edwards
Journal:  Curr Med Res Opin       Date:  2010-11-04       Impact factor: 2.580

Review 6.  Gout and its comorbidities.

Authors:  Michael H Pillinger; David S Goldfarb; Robert T Keenan
Journal:  Bull NYU Hosp Jt Dis       Date:  2010

Review 7.  Febuxostat for the management of hyperuricaemia in patients with gout: a NICE single technology appraisal.

Authors:  Matt Stevenson; Abdullah Pandor
Journal:  Pharmacoeconomics       Date:  2011-02       Impact factor: 4.981

8.  The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial.

Authors:  Michael A Becker; H Ralph Schumacher; Luis R Espinoza; Alvin F Wells; Patricia MacDonald; Eric Lloyd; Christopher Lademacher
Journal:  Arthritis Res Ther       Date:  2010-04-06       Impact factor: 5.156

9.  Quality of life and disability in patients with treatment-failure gout.

Authors:  Michael A Becker; H Ralph Schumacher; Katy L Benjamin; Peter Gorevic; Maria Greenwald; Jeffrey Fessel; Lawrence Edwards; Ariane K Kawata; Lori Frank; Royce Waltrip; Allan Maroli; Bill Huang; John S Sundy
Journal:  J Rheumatol       Date:  2009-03-30       Impact factor: 4.666

Review 10.  A prescription for lifestyle change in patients with hyperuricemia and gout.

Authors:  Hyon K Choi
Journal:  Curr Opin Rheumatol       Date:  2010-03       Impact factor: 5.006
View more
  438 in total

1.  Medically managed gout precipitating acute carpal tunnel syndrome.

Authors:  Logan Carr; Sebastian Brooke; John Ingraham
Journal:  Hand (N Y)       Date:  2015-09

2.  Gout: Why compare the effectiveness of suboptimal gout management?

Authors:  Nicola Dalbeth; Lisa K Stamp
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

3.  Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis.

Authors:  Eric Jutkowitz; Fernando Alarid-Escudero; Hyon K Choi; Karen M Kuntz; Hawre Jalal
Journal:  Pharmacoeconomics       Date:  2017-10       Impact factor: 4.981

Review 4.  The management of gout.

Authors:  Andrew Finch Rheumatology; Paul Kubler Rheumatologist
Journal:  Aust Prescr       Date:  2016-08-01

Review 5.  The gouty tophus: a review.

Authors:  Ashika Chhana; Nicola Dalbeth
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

Review 6.  Treatment Options for Gout.

Authors:  Bettina Engel; Johannes Just; Markus Bleckwenn; Klaus Weckbecker
Journal:  Dtsch Arztebl Int       Date:  2017-03-31       Impact factor: 5.594

7.  Improvement in OMERACT domains and renal function with regular treatment for gout: a 12-month follow-up cohort study.

Authors:  Janitzia Vazquez-Mellado; Ingris Peláez-Ballestas; Rubén Burgos-Vargas; Everardo Alvarez-Hernández; Sergio García-Méndez; Virginia Pascual-Ramos; Marina Rull-Gabayet
Journal:  Clin Rheumatol       Date:  2018-03-15       Impact factor: 2.980

8.  Effects of the Dietary Approaches to Stop Hypertension (DASH) Diet and Sodium Intake on Serum Uric Acid.

Authors:  Stephen P Juraschek; Allan C Gelber; Hyon K Choi; Lawrence J Appel; Edgar R Miller
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

9.  Goals of gout treatment: a patient perspective.

Authors:  Jasvinder A Singh
Journal:  Clin Rheumatol       Date:  2018-08-04       Impact factor: 2.980

10.  New ACR guidelines for gout management hold some surprises.

Authors:  Thomas Bardin; Pascal Richette
Journal:  Nat Rev Rheumatol       Date:  2012-12-11       Impact factor: 20.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.